Determining PARP Inhibition as a Treatment Strategy in Melanoma Based on Homologous Recombination Deficiency-Related Loss of Heterozygosity

Alice Zhou, Omar Butt, Michael Ansstas, Elizabeth Mauer, Karam Khaddour, George Ansstas

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Determining PARP Inhibition as a Treatment Strategy in Melanoma Based on Homologous Recombination Deficiency-Related Loss of Heterozygosity'. Together they form a unique fingerprint.

Medicine & Life Sciences